Sirolimus (American Health Packaging)


Welcome to the PulseAid listing for the Sirolimus drug offered from American Health Packaging. This Decreased Immunologic Activity [PE],mTOR Inhibitor Immunosuppressant [EPC],mTOR Inhibitors [MoA],Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: American Health Packaging
NON-PROPRIETARY NAME: Sirolimus
SUBSTANCE NAME: SIROLIMUS
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Immunologic Activity [PE],mTOR Inhibitor Immunosuppressant [EPC],mTOR Inhibitors [MoA],Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2015-03-31
END MARKETING DATE: 0000-00-00


Sirolimus HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSirolimus from American Health Packaging
LABELER NAME: American Health Packaging
DEA SCHEDULE:
ACTIVE STRENGTH: 0.5(mg/1)
START MARKETING DATE: 2015-03-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68084-956_245791af-d405-2e56-e054-00144ff8d46c
PRODUCT NDC: 68084-956
APPLICATION NUMBER: ANDA201676

Other SIROLIMUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Health PackagingSirolimus
Cadila Healthcare Limitedsirolimus
Cardinal HealthRapamune
Dr. Reddy’s Laboratories LimitedSirolimus
Greenstone LLCSirolimus
Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.Rapamune
Zydus Pharmaceuticals (USA) Inc.sirolimus